Can anybody describe Remdesivir? Anybody want to speak to that? If not, I'll do that for another hearing. I mean, just The conflict of interest of how [Remdesivir] was being approved. Okay, Wave off on that. But what we uniquely found, and my collaborators in South Africa, Risha Petorius and Doug Kell at University of Liverpool, was that the Spike protein … (05:31–05:34)
CLAIM
Asserts there was a conflict of interest in the approval process of Remdesivir.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
